Adherence to neurologic treatment. Lessons from multiple sclerosis;Therapieadhärenz in der neurologischen praxis. Beispiel: Multiple sklerose

Nervenarzt

Volumn 79, Issue 8, 2008, Pages 877-890

  Kern, S ^a   Reichmann, H ^a   Ziemssen, T ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Adherence; Compliance; Immunomodulator; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE;

COGNITION; DEPRESSION; FOLLOW UP; HEALTH PROGRAM; HUMAN; IMMUNOMODULATION; LONG TERM CARE; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; REVIEW;

GERMANY; HUMANS; MULTIPLE SCLEROSIS; NEUROLOGY; PATIENT COMPLIANCE;

EID: 49249127082     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-008-2419-0     Document Type: Review

References (68)

1. Andrejak 2000 Am J Hypertens 13 184
2. Baker 2007 Arch Intern Med 167 1503
3. Bandura 2004 Health Educ Behav 31 143
4. Bartlett 1984 J Chronic Dis 37 755
5. Bell 2007 J Manag Care Pharm 13 245
6. Broderick 2004 Psychoneuroendocrinology 29 636
7. Brody 1980 Arch Intern Med 140 1286
8. Chan 2001 Intern Med J 31 199
9. Chwastiak 2002 Am J Psychiatry 159 1862
10. Claxton 2001 Clin Ther 23 1296
11. Coleman 1985 J Hypertens Suppl 3 S69
12. Cox 2006 J Neurosci Nurs 38 167
13. D 2006 Disabil Rehabil 28 307
14. Dimatteo 1995 Formulary 30 596
15. Dimatteo 2004 Health Psychol 23 207
16. Dimatteo 2004 Med Care 42 200
17. Dimatteo 2000 Arch Intern Med 160 2101
18. Durelli 2002 Lancet 359 1453
19. Facione 1999 Oncol Nurs Forum 26 689
20. Farmer 2007 Oncol Nurs Forum 34 117
21. Feinstein 2005 CNS Spectr 10 362
22. Fraser 2001 J Neurosci Nurs 33 231
23. Fraser 2004 J Neurosci Nurs 36 120
24. Gray 2001 Ann Pharmacother 35 539
25. Haynes 2005 Cochrane Database Syst Rev 4 CD000011
26. Hunot 2007 Prim Care Companion J Clin Psychiatry 9 91
27. Julian 2007 Mult Scler 13 81
28. Katapodi 2002 Oncol Nurs Forum 29 845
29. Kobelt G, Berg J, Lindgren P et al. (2006) Costs and quality of life of multiple sclerosis in Germany. Eur J Health Econ [Suppl 2] 7: S34-S44
30. Kudielka 2003 Psychosom Med 65 313
31. Lee 1996 Am J Hypertens 9 719
32. Liebl 2001 Dtsch Med Wochenschr 126 585
33. Macintyre 2005 Prev Med 40 41
34. Maclaughlin 2005 Drugs Aging 22 231
35. Malhotra 2001 Postgrad Med J 77 703
36. Meichenbaum D, Turk DC (1994) Therapiemotivation des Patienten. Huber, Bern
37. Mohr 2001 Ann Behav Med 23 125
38. Mohr 2002 J Behav Ther Exp Psychiatry 33 39
39. Mohr 2005 Mult Scler 11 182
40. Mohr 1997 Arch Neurol 54 531
41. Mohr 1996 Mult Scler 2 222
42. Mohr 1999 Mult Scler 5 192
43. Mohr 2006 Mult Scler 12 204
44. Mohr 1998 Mult Scler 4 487
45. Morris 2006 Pharmacotherapy 26 483
46. Morris 1979 Am J Public Health 69 47
47. Morrow 1988 J Am Geriatr Soc 36 1147
48. Ownby 2006 Geriatrics 61 30
49. Ownby 2006 Aging Ment Health 10 378
50. Prosser 2004 Value Health 7 554
51. Pullar 1988 Clin Pharmacol Ther 44 540
52. Pullar 1989 Clin Pharmacol Ther 46 163
53. Pullar 1988 Br J Rheumatol 27 381
54. Raehl 2002 Pharmacotherapy 22 1239
55. Roter 1998 Med Care 36 1138
56. Rudd 1988 Am J Hypertens 1 309
57. Ruggieri 2003 Neurol Sci 24 361
58. Siegel 2007 Am J Med 120 26
59. Van 2007 BMC Health Serv Res 7 55
60. Van 2003 Drugs Aging 20 229
61. Vik 2006 Drugs Aging 23 345
62. Who (2003) Adherence to Long-term Therapies. WHO, Genf
63. Yiannakopoulou 2005 Eur J Cardiovasc Prev Rehabil 12 243
64. Tremlett 2003 Neurology 61 551
65. Milanese 2003 J Neurol Neurosurg Psychiatry 74 1689
66. Rio 2005 Mult Scler 11 306
67. Haas 2005 Eur J Neurol 12 425
68. O 2005 Mult Scler 11 46